Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7171 AL 7185

Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting

Pathak K, Ahmad MZ, Saikia R, Pathak MP, Sahariah JJ, Kalita P, Das A, Islam MA, Pramanik P, Tayeng D, Abdel-Wahab BA.

Cent Nerv Syst Agents Med Chem. 2025;25(1):3-19. doi: 10.2174/0118715249281331240325042642.

Flavonoids and Alzheimer's disease: reviewing the evidence for neuroprotective potential

Al Amin M, Dehbia Z, Nafady MH, Zehravi M, Kumar KP, Haque MA, Baig MS, Farhana A, Khan SL, Afroz T, Koula D, Tutone M, Nainu F, Ahmad I, Emran TB.

Mol Cell Biochem. 2025 Jan;480(1):43-73. doi: 10.1007/s11010-023-04922-w. Epub 2024 Apr 3.

Graphene Oxide, a Prominent Nanocarrier to Reduce the Toxicity of Alzheimer's Proteins: A Revolution in Treatment

Singh D, Kurmi BD, Singh A.

Recent Pat Nanotechnol. 2025;19(4):572-580. doi: 10.2174/0118722105292940240502114430.

Fyn Kinase in Alzheimer's Disease: Unraveling Molecular Mechanisms and Therapeutic Implications

Meur S, Karati D.

Mol Neurobiol. 2025 Jan;62(1):643-660. doi: 10.1007/s12035-024-04286-2. Epub 2024 Jun 18.

Protective effect of flavonoids on oxidative stress injury in Alzheimer's disease

Wang K, Chen X.

Nat Prod Res. 2025 Mar;39(5):1272-1299. doi: 10.1080/14786419.2024.2345760. Epub 2024 Jun 23.

Immunotherapies: A Treasure Trove of Alzheimer's Disease

Kolay A, Singh N, Gupta P, Shaikh AM, Goel R, Nagpal D, Chitme H.

Curr Pharm Biotechnol. 2025;26(12):1936-1949. doi: 10.2174/0113892010308600240709052539.

Melatonin: A potential nighttime guardian against Alzheimer's

Zhang Z, Xue P, Bendlin BB, Zetterberg H, De Felice F, Tan X, Benedict C.

Mol Psychiatry. 2025 Jan;30(1):237-250. doi: 10.1038/s41380-024-02691-6. Epub 2024 Aug 11.

Apolipoprotein E in Alzheimer's Disease: Focus on Synaptic Function and Therapeutic Strategy

Qu L, Xu S, Lan Z, Fang S, Xu Y, Zhu X.

Mol Neurobiol. 2025 Mar;62(3):3040-3052. doi: 10.1007/s12035-024-04449-1. Epub 2024 Aug 31.

Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer's Disease: An Educational Literature Review

Moawad MHED, Serag I, Alkhawaldeh IM, Abbas A, Sharaf A, Alsalah S, Sadeq MA, Shalaby MMM, Hefnawy MT, Abouzid M, Meshref M.

Mol Neurobiol. 2025 Jun;62(6):6785-6810. doi: 10.1007/s12035-024-04468-y. Epub 2024 Sep 10.

Stem Cells as a Novel Source for Regenerative Medicinal Applications in Alzheimer's Disease: An Update

Pandey K, Srivastava P, Pandey SK, Johari S, Bhatnagar P, Sonane M, Mishra A.

Curr Mol Med. 2025;25(2):146-166. doi: 10.2174/0115665240334785240913071442.

Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer's disease

Kushwaha N, Panjwani D, Patel S, Ahlawat P, Yadav MR, Patel AS.

J Drug Target. 2025 Feb;33(2):185-205. doi: 10.1080/1061186X.2024.2417012. Epub 2024 Oct 21.

Cutting-edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease

Inamdar A, Gurupadayya B, Halagali P, Nandakumar S, Pathak R, Singh H, Sharma H.

Curr Pharm Des. 2025;31(8):598-618. doi: 10.2174/0113816128344571241018154506.

Disease-modifying therapies for Alzheimer's disease: Clinical trial progress and opportunity

Zhang Y, Chen J, Li Y, Jiao B, Luo S.

Ageing Res Rev. 2025 Jan;103:102595. doi: 10.1016/j.arr.2024.102595. Epub 2024 Nov 22.

Recent Studies on Heterocyclic Cholinesterase Inhibitors Against Alzheimer's Disease

Tok F.

Chem Biodivers. 2025 Apr;22(4):e202402837. doi: 10.1002/cbdv.202402837. Epub 2024 Dec 3.

The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia

Mohammad Hosseini A, Khaleghzadeh-Ahangar H, Rahimi A.

Neuroscience. 2025 Jan 9;564:271-280. doi: 10.1016/j.neuroscience.2024.11.062. Epub 2024 Nov 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias